Categories: Research

Publication highlight: Williams

SynNotch T cells drive customized therapeutic responses for cancer and other diseases. SynNotch T cells can be engineered to sense tumor antigens and locally deliver biologics such as antibodies, and can thus be used as a smart platform for local delivery of diverse therapeutic payloads capable of...

Yeast in a class of their own

The ability of an organism to grow and reproduce, that is, its “fitness,” is determined by how its genes interact with the environment. Yeast is a model organism in which researchers can control the exact mutations present in the yeast’s genes (its genotype) and the conditions in which the yeast...

Gartner to co-direct new UCSF-based Center for Cellular Construction

UCSF School of Pharmacy faculty member Zev Gartner, PhD, will be co-director of a new multi-institution UCSF-administered Center for Cellular Construction, which has been awarded a five-year $24 million grant by the National Science Foundation (NSF).

Researchers develop safer opioid painkiller from scratch

Brian Shoichet, PhD, professor of pharmaceutical chemistry in the UCSF School of Pharmacy, is co-senior author of a study published in Nature that used the newly deciphered atomic structure of the brain’s “morphine receptor” to custom engineer a novel drug candidate that blocked pain as effectively...

Renewed funding for Aweeka study on malaria treatment for children with HIV in Africa

Fran Aweeka, PharmD, will receive renewed funding for her grant from the National Institutes of Health for evaluating the pharmacology of antimalarial drugs in children in Africa. This is a renewal of her R01 on this important work, and will provide five years of funding for Aweeka and her...

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Pages